The abstract is read at the publisher; the summary is JClub's.
In a dataset of 614 antibodies tested with knockout controls, 97 (15.8%) failed across all applications, and linked papers used 8,064 animal samples and 4,424 human tissue samples at risk of waste.
- Why it matters: Poor antibody validation can misdirect biomedical research, but the avoidable ethical costs from wasted animal and human biological materials have not been quantified.
- What they did: Using focus groups (n = 12), surveys (n = 107), and systematic analysis of 785 publications, the study assessed selection and validation practices and linked 97 failing antibodies to 760 publications with confirmable validation status.
- The result: Only 120 of 760 (15.8%) papers showed any validation evidence, and 640 papers reported at least 8,064 animal samples and 4,424 human tissue samples used with poor-performance antibodies without evidence of fitness for the specific purpose.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.